Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04165109 · ClinicalTrials.gov registry record
Trial-Ready Cohort-Down Syndrome (TRC-DS)
A clinical trial of Alzheimer Disease and Dementia, sponsored by University of Southern California.
- Recruiting
- Registry status
- 450
- Enrollment target
- 20
- Study locations
NCT04165109 is a study of Alzheimer Disease and Dementia that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 450 participants, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% lower). The trial reports 20 study locations across 18 states.
The verdict
NCT04165109, a study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC), and up to 450 participants in total including co-enrolled in the Alzheimer Biomarkers Consortium - Down Syndrome (ABC-DS) study. Participants enrolled in the TRC-DS will undergo longitudinal cognitive and clinical assessment, genetic and biomarker testing, as well as imaging and biospecimen collection. Using these outcome measures, researchers will analyze the relationships between cognitive measures and biomarkers of Alzheimer's disease (AD) to identify endpoints for AD clinical trials in DS that best reflect disease progression. To learn more about the study and participating sites, visit our study website at: https://www.trcds.org/. TRC-DS is collaborating with the Alzheimer's Disease Biomarker Consortium-Down Syndrome (ABC-DS) to allow study participants to be concurrently enrolled in both ABC-DS and TRC-DS, referred to as "co-enrollment". ABC-DS is a longitudinal, observational research study that is overseen at University of Pittsburgh Coordinating Center. ABC-DS participants who express interest in potentially joining a clinical trial in the future and who meet TRC-DS eligibility criteria, may choose to co-enroll in TRC-DS at an ABC-DS Site. Co-enrolled participants will adhere to the ABC-DS protocol and schedule of activities, but agree to share their data with the TRC-DS team and to receive invitations for future participation in clinical trials. Fore more information on ABC-DS please visit https://www.nia.nih.gov/research/abc-ds or http://abcds.pitt.edu/.
Conditions Studied
Study Locations (20)
Ohio
- Case Western Reserve University - Beachwood
- University of Cincinnati - Cincinnati
Other
- Sant Pau Biomedical Research Institute (IIB Sant Pau) - Barcelona
- University of Cambridge, Co-Enrolling through ABC-DS Only - Cambridge
Arizona
- Barrow Neurological Institute - Phoenix
California
- University of California, Irvine School of Medicine, Co-Enrolling through ABC-DS Only - Orange
Colorado
- Linda Crnic Institute for Down Syndrome, University of Colorado - Aurora
Illinois
- Advocate Medical Group Adult Down Syndrome Center - Park Ridge
Indiana
- Indiana University - Indianapolis
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2021-06-07 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04165109
The ClinicalTrials.gov registry entry for NCT04165109 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 0 interventions.
NCT04165109 reports 20 study locations spanning 18 distinct geographic areas - top geographies include Ohio, Other, Arizona.
Frequently Asked Questions
What is clinical trial NCT04165109 about?
NCT04165109 is a clinical study titled "Trial-Ready Cohort-Down Syndrome (TRC-DS)". The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC), and up to 450 participants in total including co-enrolled in the Alzheimer Biomarkers Consortium - Down Syndrome (ABC-DS...
What is the current status of trial NCT04165109?
This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2021-06-07. Estimated completion is 2027-12-31.
What conditions does trial NCT04165109 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Down Syndrome.
Who is sponsoring clinical trial NCT04165109?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04165109 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
RECRUITING · Phase 3
-
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
RECRUITING · Phase 4
-
Systemic and Central Inflammation in AD
RECRUITING · Phase 2
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
RECRUITING · Phase 1
-
Cognitive Neurology Unit Clinical Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.